Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Industry Trends

Clinical Trial Trends

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Disease Area Trends

Recent Tweets

The pipeline of gene therapies in testing has grown, and so have the challenges. https://buff.ly/3Pqolxv #immunotherapy #pipeline #FDA

Pharvaris $PHVS jumps more than 60% 🔺 as the company announces positive P2 trial data for PHVS416 as an oral, on-demand treatment for hereditary angioedema attacks.
#HAE #stocks #pharma

$LPTX Tough action lately, good opp to revisit fundamentals. Highlights for me:

Distinguish Part A 1L
- DKN01 combo: 68.2% ORR, 11.3 mPFS ✅
- Checkmate-649: 47% ORR, 7.7 mPFS
- Especially 👇
- DKN01 combo: 18 months mOS *& COUNTING* ✅
- Checkmate-649: 13.8 months

GSK's Jemperli hits its primary endpoint against Merck's Keytruda in an NSCLC phase 2 trial. https://buff.ly/3Fd7XeH $GSK $MRK #NSCLC #clinicaltrials

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762